Establishing of ‘Pakistan-China Pharma Portal’ proposed
LAHORE: Commercial Ambassador of Pakistan China Joint Chamber of Commerce and Industry (PCJCCI), Adeel Munawar, has proposed the establishment of a ‘Pakistan-China Pharma Portal’ to strengthen bilateral cooperation in the pharmaceutical sector.
In a statement he said the dedicated digital platform would facilitate trade, technology transfer, investment, research collaboration, regulatory coordination, and business networking between pharmaceutical stakeholders of both countries.
He stated that Pakistan and China have already built a strong strategic partnership across various sectors, and the pharmaceutical industry now presents immense opportunities for expanding bilateral economic cooperation. The proposed portal would serve as a one-stop platform connecting pharmaceutical manufacturers, exporters, importers, investors, researchers, healthcare professionals, and regulatory authorities, enabling them to collaborate more effectively and explore new business opportunities.
Adeel Munawar said that China has made remarkable progress in pharmaceutical innovation and manufacturing through sustained investment in research and development, advanced technologies, scientific excellence, and internationally recognized quality standards. Pakistan, he added, can greatly benefit from China’s expertise by strengthening institutional collaboration and facilitating greater interaction between the pharmaceutical industries of both countries.
According to him, the establishment of a Pakistan-China Pharma Portal will create a centralized digital ecosystem for the pharmaceutical sector, providing access to market intelligence, investment opportunities, regulatory updates, product directories, business matchmaking services, and technology partnerships. Adeel observed that Pakistan’s pharmaceutical industry has witnessed significant growth over recent years and possesses considerable untapped export potential. Although local manufacturers have expanded production capacity, there is still substantial room for improving technological capabilities, research collaboration, and integration into global pharmaceutical supply chains. Closer cooperation with China would enable Pakistani companies to adopt advanced manufacturing practices, modern pharmaceutical equipment, bio-similar technologies, and innovative drug delivery systems.
Reaffirming PCJCCI’s commitment to promoting sector-specific collaboration, Adeel called upon policymakers, pharmaceutical companies, research institutions, investors, and healthcare organizations from both countries to support the establishment of the Pakistan-China Pharma Portal. He described the initiative as a transformative step that would strengthen bilateral trade, accelerate technological cooperation, and create a robust pharmaceutical ecosystem capable of addressing future healthcare challenges while reinforcing the longstanding friendship between Pakistan and China.
Copyright Business Recorder, 2026